JPRN-UMIN000000482未知2 期
A phase II study for anaplastic thyroid cancer - A phase II study for anaplastic thyroid cancer
agoya university hospital0 个研究点目标入组 20 人开始时间: 2006年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •heavy thoracic, abdominal, or pericardial dropsy; heavy complications such as myocarial infarction, heat failure, cerebral infarctio within 6 months; uncontrolled diabetes; uncontrolled hypertension;symptomatic brain metastases;
研究者
相似试验
进行中（未招募）
1 期
The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 MutationAnaplastic Thyroid CancerATCNCT05102292Shanghai Henlius Biotech25
进行中（未招募）
1 期
A Pilot Study in Metastatic Advanced Thyroid Cancer Evaluating the Safety and Efficacy of Sorafenib - MATiSSePatients with localled advanced or metastatic thyroid cancer . histological sub-types will include differentiated and medullary thyroid cancer.EUCTR2006-006615-80-GBRoyal Marsden Nhs Foundation Trust33
Unknown
2 期
Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)Anaplastic Thyroid CancerNCT04574817Taizhou Hanzhong biomedical co. LTD66
进行中（未招募）
不适用
Study for metastatic thyroid cancer using 124i and [18F] FDG PET / CT in patients with elevated values of Tg and / or AbTg with negative ultrasonography of the neck, previously treated with thyroidectomy and radioiodine therapy. - I124Only patiensMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2010-023831-40-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
进行中（未招募）
不适用
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.Thyroid Cancer Stage IVRadiation ToxicityNCT03669432Tata Memorial Hospital72